DOVID RIBAKOW: Open Payments
NPI 1972035129 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,001 in 28 payments from 5 companies in 2025. Trend: 2023 $2,614 · 2024 $425 · 2025 $6,001
Consulting: $5,340Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $2,550 |
| Janssen Biotech, Inc. | 18 | $1,855 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,140 |
| ABBVIE INC. | 5 | $401 |
| PFIZER INC. | 2 | $55 |
Products named: OMVOH, TREMFYA, SKYRIZI, RINVOQ, VELSIPITY, XELJANZ.
Industry payments across OH — which companies pay providers there.
